Literature DB >> 32301199

Estimation of basic reproduction number for COVID-19 and the reasons for its differences.

Hadis Najafimehr1, Kosar Mohamed Ali2, Saeed Safari3, Mahmoud Yousefifard4, Mostafa Hosseini1.   

Abstract

Entities:  

Year:  2020        PMID: 32301199      PMCID: PMC7262308          DOI: 10.1111/ijcp.13518

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   3.149


× No keyword cloud information.
To the Editor, The novel coronavirus pneumonia is an acute respiratory disease. In December 2019, this disease emerged in Wuhan, China. The Chinese government called it SARS‐CoV‐2 which was subsequently named COVID‐19 by the World Health Organization (WHO). In January 2020, WHO confirmed it as a sustained human to human disease. By March 2020, COVID‐19 had been transmitted round the world rapidly and everyday large number of new cases were registered. COVID‐19 is a leaped type of coronavirus family, such as severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS), that has been transmitted from wild animals to human. Since COVID‐19 has become a global concern, much research has been done to control its transmission. Basic reproduction number (R 0) is one of the most widely used concept in epidemiology for understanding the contagiousness of an infectious agent. R 0 is the average number of new infections produced by an infectious patient in a given population. This concept, which is calculated as a numerical index, is used when there is a dynamic infectious disease and the population is not vaccinated. There are three values for this index followed by three interpretations: if it is greater than one, the contagion is expected to continue. If smaller than one, it means that the contagion is running out and if equal to one it implies that almost the stability conditions are dominated. Hence, R 0 can represent a potential measure of the contagion of a contagious disease. The present study gives a brief discussion on key aspects of the concept of R 0 and its significance to the coronavirus pandemic. As at March 2020, several studies have calculated R 0 in different populations for COVID‐19. Most of these studies are from China and cover the first 2 months of 2020. Investigation on these studies revealed that the minimum R 0 for China and overseas was 1.4 while the maximum was 7.23. For Italy, it was estimated as 4.2. Moreover, these values were larger compared to SARS and MERS. Therefore, COVID‐19 can be considered as a high transmission disease with respect to SARS and MERS. The method of calculation in these studies included mathematical, statistical or stochastic methods. A review article by Liu et al, which investigated some of these studies, shows that in articles using the stochastic method, the mean R 0 is 2.44 and in the mathematical methods the mean is 4.2 and for studies which used the statistical method is 2.6. Comparison of these numbers shows that the mathematical method had larger values compared with other methods. Moreover, the estimated R 0 values were larger than that of the WHO (range 1.4‐2.5). R 0 is a biological fact which is calculated using complex mathematical models and with a set of assumptions about the population under study. Therefore, the interpretation of these models needs an understanding of the initial model and its inputs. Usually, three parameters—(a) the duration of contagiousness after a person becomes infected, (b) the likelihood of infection per contact between a susceptible person and an infectious person or vector and (c) the contact rate—are used in the construction of the R 0, each of them may differ in the population under study. Epidemiological factors such as environmental conditions, agent hosts, governments’ policies on environmental control and access to public health resources also can in turn change in mentioned parameters. Another factor which can change the model's parameters is the contact rate, while factors such as population density, social organisation and seasonality may cause variation in contact rate. On the other hand, many model parameters are dependent on the available data, and here the quality of the data is definitely important. In critical situations such as the contagion of COVID‐19, it may be difficult to collect accurate and definitive data. However, some studies have used data‐driven methods to estimate R 0 in COVID‐19. Therefore, when estimating a value for R 0 at a given place and time, using different models which differ slightly in initial assumptions could lead to different estimates. One of the most effective strategies of controlling the spread of contagious infections is quarantine. It prevents infected people from contacting the susceptible population. Another is isolation, in which the sick person is separated from healthy people. These strategies have shown beneficial effects in similar diseases and can also be effective in reducing R 0 of COVID‐19. Differences in R 0 estimates can be a controversial issue, but are not reasons for R 0 inefficiency. R0 index may differ by time, hence its value should be coordinated by time. In conclusion, R 0 is a very useful index when making decisions to control infectious diseases including COVID‐19, considering its specific population structure. However, in using the initial assumption for any model, precaution is needed.

DISCLOSURE

None.
  7 in total

Review 1.  The estimation of the basic reproduction number for infectious diseases.

Authors:  K Dietz
Journal:  Stat Methods Med Res       Date:  1993       Impact factor: 3.021

Review 2.  The reproductive number of COVID-19 is higher compared to SARS coronavirus.

Authors:  Ying Liu; Albert A Gayle; Annelies Wilder-Smith; Joacim Rocklöv
Journal:  J Travel Med       Date:  2020-03-13       Impact factor: 8.490

3.  Correcting the actual reproduction number: a simple method to estimate R(0) from early epidemic growth data.

Authors:  Hiroshi Nishiura
Journal:  Int J Environ Res Public Health       Date:  2010-01-21       Impact factor: 3.390

4.  Complexity of the Basic Reproduction Number (R0).

Authors:  Paul L Delamater; Erica J Street; Timothy F Leslie; Y Tony Yang; Kathryn H Jacobsen
Journal:  Emerg Infect Dis       Date:  2019-01       Impact factor: 6.883

5.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

6.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

7.  Superspreading and the effect of individual variation on disease emergence.

Authors:  J O Lloyd-Smith; S J Schreiber; P E Kopp; W M Getz
Journal:  Nature       Date:  2005-11-17       Impact factor: 49.962

  7 in total
  8 in total

1.  Investigation of turning points in the effectiveness of Covid-19 social distancing.

Authors:  C Neuwirth; C Gruber
Journal:  Sci Rep       Date:  2022-10-22       Impact factor: 4.996

2.  An Adaptive Information Borrowing Platform Design for Testing Drug Candidates of COVID-19.

Authors:  Liwen Su; Jingyi Zhang; Fangrong Yan
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-04-22       Impact factor: 2.585

3.  Towards Covid-19 Literacy: Investigating the Literacy Levels of University Students in Colombia.

Authors:  Pablo Antonio Archila; Giovanna Danies; Jorge Molina; Anne-Marie Truscott de Mejía; Silvia Restrepo
Journal:  Sci Educ (Dordr)       Date:  2021-04-19       Impact factor: 2.114

4.  Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.

Authors:  Yan Niu; Li Luo; Shiting Yang; Guzainuer Abudurusuli; Xiaoye Wang; Zeyu Zhao; Jia Rui; Zhuoyang Li; Bin Deng; Weikang Liu; Zhe Zhang; Kangguo Li; Chan Liu; Peihua Li; Jiefeng Huang; Tianlong Yang; Yao Wang; Tianmu Chen; Qun Li
Journal:  Front Public Health       Date:  2022-09-15

Review 5.  Clinical features of COVID-19 and SARS epidemics. A literature review.

Authors:  Antonella Zizza; Virginia Recchia; Alessandra Aloisi; Marcello Guido
Journal:  J Prev Med Hyg       Date:  2021-04-29

6.  Surgery at the time of COVID-19 pandemic: initial evidence of safe practice.

Authors:  G Del Genio; F Merlino; S Tolone; L Brusciano; F S Lucido; L Docimo; C Gambardella
Journal:  Br J Surg       Date:  2020-06-03       Impact factor: 6.939

Review 7.  COVID-19, Chikungunya, Dengue and Zika Diseases: An Analytical Platform Based on MALDI-TOF MS, IR Spectroscopy and RT-qPCR for Accurate Diagnosis and Accelerate Epidemics Control.

Authors:  Jéssica Costa; Eugénio C Ferreira; Cledir Santos
Journal:  Microorganisms       Date:  2021-03-30

8.  COVID-19 Vaccines Cost-Effectiveness Analysis: A Scenario for Iran.

Authors:  Atefeh Vaezi; Alipasha Meysamie
Journal:  Vaccines (Basel)       Date:  2021-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.